Dr. Deepak A. Kapoor Interviewed About Treatment Options for Advanced Stage Prostate Cancer

Theodore Cohen, contributor to SeekingAlpha.com interviewed Dr. Deepak A. Kapoor about Dendreon’s Provenge, Johnson and Johnson’s Zytiga, and Medivation’s Xtandi. “In our practice we manage patients based on prospective clinical guidelines based best practice models developed from evidence-based medicine and national consensus clinical protocols” says Dr. Kapoor. To read the complete interview, please click here.

Read More

Dr. Deepak A. Kapoor at Yankee Stadium for Prostate Cancer Awareness Month

Dr. Deepak A. Kapoor at Yankee Stadium for Prostate Cancer Awareness Month During the Yankees/Blue Jays game on September 20, 2012, Dr. Deepak A. Kapoor discussed the importance of prostate cancer screening with Ken Singleton. September is prostate cancer awareness month and a special time to raise awareness for this important issue. Click below to hear the […]

Read More

Advanced Urology Centers of New York Creates State-Of-The-Art Outpatient Urologic Facility in Bethpage

Melville, New York September 4, 2012 – Advanced Urology Centers of New York (AUCNY), the largest independent provider of urology services in the United States, opened a new facility at 480 Hicksville Road, Bethpage, NY 11714. This new location will provide current and future patients with a state-of-the-art facility for comprehensive urological care. You can […]

Read More

Michael Nagar, MD “Gleason pattern 5 is frequently underdiagnosed on prostate needle-core biopsy” published in Urology in January 2012.

In addition, Dr. Nagar presented his abstract, “Gleason pattern 5 is frequently underdiagnosed on prostate needle-core biopsy” at the United States & Canadian Academy of Pathology (USCAP) Annual Meeting in Vancouver. The USCAP Meeting is the largest educational gathering of physician pathologists, sharing information was held in March 2012. You can read it by clicking […]

Read More